Cargando…
T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1
Autores principales: | Bhattacharyya, J, Mihara, K, Kitanaka, A, Yanagihara, K, Kubo, T, Takei, Y, Kimura, A, Takihara, Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389163/ https://www.ncbi.nlm.nih.gov/pubmed/22829977 http://dx.doi.org/10.1038/bcj.2012.21 |
Ejemplares similares
-
All-trans retinoic acid and interferon-α increase CD38 expression on adult T-cell leukemia cells and sensitize them to T cells bearing anti-CD38 chimeric antigen receptors
por: Mihara, K, et al.
Publicado: (2016) -
All-trans retinoic acid enhances cytotoxic effect of T cells with an anti-CD38 chimeric antigen receptor in acute myeloid leukemia
por: Yoshida, Tetsumi, et al.
Publicado: (2016) -
T cells bearing anti-CD19 and/or anti-CD38 chimeric antigen receptors effectively abrogate primary double-hit lymphoma cells
por: Mihara, Keichiro, et al.
Publicado: (2017) -
Overexpression of the Survivin gene in SGC7901 cell resistance to cisplatin
por: DONG, HANZHANG, et al.
Publicado: (2014) -
BMI1 enables interspecies chimerism with human pluripotent stem cells
por: Huang, Ke, et al.
Publicado: (2018)